Skip to Content
Skip to Content

Substance evaluation - CoRAP

Substance evaluation - CoRAP

If a substance is on this list, it means that a Member State has evaluated or will evaluate it over the coming years. The list is called the Community rolling action plan (CoRAP).

For each substance, the table shows the evaluating Member State, the (planned) year of evaluation and a short description of the concern which led to it being placed on the list.

Documents to do with substance evaluation are also available here. They include: documents justifying selection of the substances, decisions to request more information.  Member States' conclusions and Member States' final evaluation reports are included for substances for which evaluation has been finalised.

 

Notes to the Substance Evaluation table
  • Where two Members States are indicated, this is a joint evaluation. The first Member State mentioned leads the Evaluation and is the responsible competent authority in the meaning of Article 45(2) of REACH.
  • The substance public name is used. In most of the cases it is the name as disseminated on the ECHA website.
  • When the EC Number is not available, the number assigned to substance by ECHA after the inquiry process is used.
  • When the substances are included in the CoRAP, they have not yet been evaluated and thus the concern is indicative and not exhaustive or conclusive.
  • Contact details of the evaluating Member States are provided for all the substance included.
  • Please note that the justification document explains the grounds of the initial concerns that triggered the inclusion of the substance in the CoRAP for further clarification under substance evaluation. The justification document is based on a preliminary screening of the substance and is without prejudice to the outcome of the substance evaluation.

Legend:

Suspected PBT/vPvB: Potentially Persistent, Bioaccumulative and Toxic/very Persistent and very Bioaccumulative.
CMR: generic term for known carcinogenic and/or mutagenic and/or reprotoxic properties (according to CLP harmonised or registrant self-classification or CLP Inventory). The concern can refer to C, M, R or a combination of those.
Suspected CMR: generic term for suspected carcinogenic and/or mutagenic and/or reprotoxic properties (not classified according to CLP harmonised or registrant self-classification). The concern can refer to (suspected) C, M, R or a combination of those.
Sensitiser: generic term for known sensitising properties (according to CLP harmonised or registrant self-classification or CLP Inventory).
Suspected sensitiser: generic term for suspected sensitising properties (not classified according to CLP harmonised or registrant self-classification).
RCR: Risk Characterisation Ratio 

Last updated 25 March 2020. Database contains 382 unique substances/entries.
Filter the list
Initial grounds for concern:

 
215-477-2
1327-41-9
2015
France
Suspected CMR
High (aggregated) tonnage
Information requested
Details
231-208-1
7446-70-0
2015
France
Suspected CMR
Exposure of workers
High (aggregated) tonnage
High RCR
Information requested
Details
287-477-0
85535-85-9
2012
United Kingdom
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
271-231-4
68526-83-0
2016
Italy
Suspected Carcinogenic
Suspected Mutagenic
Consumer use
Exposure of workers
Wide dispersive use
Concluded
Details
247-118-0
25584-83-2
2022
France
Suspected Carcinogenic
Suspected Mutagenic
Suspected Sensitiser
Exposure of workers
High (aggregated) tonnage
High RCR
Other exposure/risk based concern
Wide dispersive use
Not started
Details
204-820-1
127-06-0
2016
Austria
Suspected Carcinogenic
Suspected Mutagenic
Suspected Sensitiser
Exposure of environment
Exposure of workers
High RCR
Wide dispersive use
Concluded
Details
283-044-5
84539-55-9
2021
Sweden
Suspected Reprotoxic
Potential endocrine disruptor
Suspected Sensitiser
Consumer use
Exposure of environment
Exposure of workers
Wide dispersive use
Not started
Details
421-820-9
192268-65-8
2022
Netherlands
Suspected PBT/vPvB
Not started
Details
458-680-3
797751-44-1
2019
Spain
Suspected PBT/vPvB
Exposure of environment
Ongoing
Details
405-040-6
63500-71-0
2012
Spain
High RCR
Wide dispersive use
Concluded
Details
422-040-1
426218-78-2
2016
Spain
Suspected PBT/vPvB
Exposure of environment
High RCR
Information requested
Details
251-020-3
32388-55-9
2022
Netherlands
Potential endocrine disruptor
Suspected PBT/vPvB
Not started
Details
246-678-3
25155-25-3
2015
Netherlands
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
219-207-4
2386-87-0
2013
Ireland
Suspected CMR
Sensitiser
Exposure of workers
High RCR
Concluded
Details
400-370-7
6196-98-1
2021
Finland
Suspected PBT/vPvB
Exposure of environment
Not started
Details
202-525-2
96-69-5
2015
Austria
Suspected CMR
Potential endocrine disruptor
Suspected PBT/vPvB
Sensitiser
Consumer use
Wide dispersive use
Information requested
Details
201-618-5
85-60-9
2019
France
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Consumer use
Exposure of environment
Exposure of workers
Wide dispersive use
Ongoing
Details
204-327-1
119-47-1
2016
Denmark
Suspected Reprotoxic
Potential endocrine disruptor
Concluded
Details
220-618-6
2835-95-2
2020
Italy
Mutagenic
Sensitiser
Other hazard based concern
Ongoing
Details
202-653-9
98-29-3
2018
Poland
Suspected Mutagenic
Potential endocrine disruptor
Suspected PBT/vPvB
Sensitiser
Exposure of environment
Exposure of workers
Concluded
Details
202-679-0
98-54-4
2014
Germany
Potential endocrine disruptor
High (aggregated) tonnage
Ongoing
Details
203-253-7
104-93-8
2012
Ireland
CMR
Consumer use
High RCR
Wide dispersive use
Concluded
Details
202-804-9
99-96-7
2014
Czech Republic
Suspected CMR
Potential endocrine disruptor
Consumer use
High (aggregated) tonnage
Concluded
Details
204-616-2
123-30-8
2020
Italy
Mutagenic
Sensitiser
Other hazard based concern
Ongoing
Details
405-520-5
95235-30-6
2021
Belgium
Potential endocrine disruptor
Other exposure/risk based concern
Not started
Details
202-966-0
101-68-8
2013
Estonia
CMR
Suspected PBT/vPvB
Sensitiser
Consumer use
Wide dispersive use
Concluded
Details
201-250-5
80-09-1
2014
Belgium
Suspected CMR
Potential endocrine disruptor
High (aggregated) tonnage
Information requested
Details
1 - 4.5 moles propoxylated
500-097-4
37353-75-6
2013
Denmark
Suspected CMR
High (aggregated) tonnage
Wide dispersive use
Conclusion under preparation
Details
701-276-1
-
Estonia
CMR
Suspected PBT/vPvB
Sensitiser
Consumer use
High (aggregated) tonnage
Wide dispersive use
Withdrawn
Details
249-204-3
28768-32-3
2013
Denmark
CMR
Wide dispersive use
Information requested
Details
233-593-1
10254-57-6
2021
Germany
Suspected PBT/vPvB
Not started
Details
Bisphenol A; BPA
201-245-8
80-05-7
2012
Germany
Potential endocrine disruptor
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
253-781-7
38103-06-9
2013
Germany
Suspected PBT/vPvB
High (aggregated) tonnage
Concluded
Details
428-970-4
13595-25-0
2014
Belgium
Suspected PBT/vPvB
Other hazard based concern
Consumer use
Exposure of environment
Concluded
Details
201-052-9
77-73-6
2016
France
Suspected Reprotoxic
Exposure of workers
High (aggregated) tonnage
High RCR
Ongoing
Details
219-785-8
2530-85-0
2015
Ireland
Suspected Sensitiser
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Follow-up
Details
215-925-7
1453-58-3
2018
Belgium
Suspected Reprotoxic
Potential endocrine disruptor
Exposure of environment
Wide dispersive use
Ongoing
Details
204-633-5
123-51-3
2021
Poland
Suspected Carcinogenic
Suspected Reprotoxic
Suspected Sensitiser
Consumer use
Exposure of workers
Not started
Details
264-727-7
64194-22-5
Slovenia
Suspected Carcinogenic
Exposure of workers
Wide dispersive use
Withdrawn
Details
435-790-1
297730-93-9
2018
Spain
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Ongoing
Details
203-680-9
109-55-7
2014
Austria
Sensitiser
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
209-711-2
591-27-5
2020
Italy
Mutagenic
Sensitiser
Other hazard based concern
Ongoing
Details
432-520-2
232938-43-1
2022
Belgium
Suspected Reprotoxic
Potential endocrine disruptor
Not started
Details
242-016-2
18127-01-0
2022
Sweden
Suspected Reprotoxic
Not started
Details
200-657-5
67-51-6
2021
Spain
Reprotoxic
High RCR
Not started
Details
221-975-0
3302-10-1
2021
Spain
Suspected Reprotoxic
Exposure of workers
Not started
Details
201-126-0
78-59-1
2013
France
CMR
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Follow-up
Details
218-407-9
2144-53-8
2016
Germany
Potential endocrine disruptor
Suspected PBT/vPvB
Other hazard based concern
Exposure of environment
Wide dispersive use
Information requested
Details
241-527-8
17527-29-6
2016
Germany
Potential endocrine disruptor
Suspected PBT/vPvB
Other hazard based concern
Exposure of environment
Wide dispersive use
Information requested
Details
202-112-7
91-97-4
2013
France
Suspected CMR
Suspected PBT/vPvB
Sensitiser
Consumer use
Concluded
Details

Export search results to:

Categories Display

Tagged as:

(click the tag to search for relevant content)


Route: .live2